patient
Mark lives symptom-free with MDS, but it's still "like an albatross"
Mark had no symptoms common to bone marrow failure patients.
Not one.
2019 update! My Son, the Athlete and Survivor - Sam Thrives Years after Transplant
What Happens in a Clinical Trial? How do I know if it's the right option for me?
Why would I choose a clinical trial? What kind of additional care would I receive? How do I know if I qualify?
Christina Cline, RN, BSN, CCRC, explains both patient and nurse navigator roles in this recent recording.
Surprised by diagnosis, Mark learns to live with low-risk Myelodysplastic Syndrome
Mark had no symptoms prior to diagnosis. Even more surprising was the "watch and wait" treatment plan! Listen to this recently recorded episode where Mark describes living as an MDS survivor now.
Alison R. Walker, MD
Dr. Walker received her MD from University of Rochester School of Medicine and Dentistry. She completed an Internal Medicine Residency and a Hematology/Oncology Fellowship at the University of Rochester, New York. She joins us from The Ohio State University, where she served as a Professor in the Department of Internal Medicine, Division of Hematology. Dr. Walker’s clinical interests are in the care of patients with myeloid malignancies, specifically
Imad Tabbara, MD
Dr. Tabbara has researched blood and bone marrow stem cell transplant. He established the bone marrow transplant program at The GWU Medical Center in 1992 and has performed several hundred stem cell transplants treating patients with leukemia, lymphoma, multiple myeloma and myelodysplastic syndrome. Additional areas of interest for Dr. Tabbara are breast and lung cancers.
Angela Smith, MD, MS
Angela Smith joined the Department of Pediatrics in July 2008 in the Division of Hematology/Oncology/Blood and Marrow Transplantation and became Director of the Division Blood and Marrow Transplantation in 2019.
Evan Shereck, MD, MEd
Dr. Shereck specializes in bone marrow transplantation for children with cancer, blood disorders and immunodeficiencies. She conducts clinical trials as a part of the Primary Immune Deficiency Treatment Consortium (PIDTC) and the Pediatric Blood and Marrow Transplant Consortium (PBMTC).
Joshua Sasine, MD, PhD
Dr.